During the past decade, Tekton Research conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 2 clinical trials were completed, i.e. on average, 25% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 2 clinical trials were completed. i.e. 33.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Tekton Research" #1 sponsor was "Pfizer" with 3 trials, followed by "Biophytis" with 1 trials sponsored, "Eli Lilly and Company" with 1 trials sponsored, "ModernaTX, Inc." with 1 trials sponsored and "Novavax" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

According to Clinical.Site data, the most researched conditions in "Tekton Research" are "Migraine" (3 trials), "COVID-19" (1 trials), "Episodic Migraine" (1 trials), "Gait Disorders in Old Age" (1 trials) and "Meningococcal Vaccine" (1 trials). Many other conditions were trialed in "Tekton Research" in a lesser frequency.

Most popular intervention types in "Tekton Research" are "Drug" (6 trials) and "Biological" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (5 trials), "Rimegepant" (2 trials), "BIO101" (1 trials), "Dihydroergotamine" (1 trials) and "Galcanezumab" (1 trials). Other intervention names were less common.

The vast majority of trials in "Tekton Research" are 7 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Tekton Research". undefined are not yet recruiting, 1 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Tekton Research, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Tekton Research, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".